Hyperfine Announces 10 Abstracts At RSNA, Highlighting The Expanding Utility And Potential Of Portable MR Brain Imaging In Diverse Clinical And Research Settings
Hyperfine Announces 10 Abstracts At RSNA, Highlighting The Expanding Utility And Potential Of Portable MR Brain Imaging In Diverse Clinical And Research Settings
The breadth of data being presented at the premier radiology meeting of 2024 illustrates the increasing relevance of portable, ultra-low-field MR brain imaging.
2024年首屈一指的放射学会议上展示的数据广度显示了便携式超低场MR脑成像日益相关的重要性。
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop system—today announced that ten scientific abstracts highlighting ultra-low-field imaging will be presented at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago. For Hyperfine, this marks the largest number of presentations at RSNA to date, underscoring the growing interest in and expanding applications of the Swoop system across varied professional healthcare environments.
Hyperfine, Inc.（纳斯达克：HYPR），是一家开创性健康科技公司，它通过首个获得FDA批准的便携式磁共振（MR）脑成像系统——Swoop系统，重新定义了脑成像。今天，Hyperfine宣布将在2024年在芝加哥举行的北美放射学会（RSNA）年会上展示十篇突出超低场成像的科学摘要。这标志着Hyperfine在RSNA上展示的演讲数量创下历史新高，突显了对Swoop系统在专业医疗环境中日益增长的兴趣和扩展应用。
